Table 4

Participants in APCaRI 03 recruited postdiagnosis of prostate cancer

Number of men in 03 protocol who consented as of 30 June 20191462
Completed intake table1438 (98%)
Completed BMI value at intake1220 (83%)
Completed PSA value at intake1435 (98%)
 Mean11.88
 Median6.5
 Range0.0–1189.0
 SD46.14
Biopsy not performed27 (2%)
Diagnostic prostate biopsy1435 (98%)
 Gleason 6493 (34%)
 Gleason 7748 (52%)
 Gleason≥8170 (12%)
 Missing24 (2%)
 Radical prostatectomy417 (29%)
 Cryotherapy99 (7%)
 Radiation (EBRT)433 (30%)
 Radiation (Brachy)99 (7%)
 Chemotherapy50 (3%)
 Active surveillance419 (29%)
 Androgen deprivation therapy526 (37%)
  • APCaRI, Alberta Prostate Cancer Research Initiative; BMI, body mass index; EBRT, external beam radiation therapy; PSA, prostate specific antigen.